These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9662844)

  • 1. [Raynaud phenomenon in childhood: review and progress control in eight cases].
    González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
    An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
    Wollersheim H; Thien T
    Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of Raynaud's phenomenon].
    Guilmot JL; Diot E; Lasfargues G
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1755-60. PubMed ID: 1685081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The determination of the thermal threshold in subjects with Raynaud's disease. A preliminary report of 2 clinical cases].
    Luca S; Romeo S
    Minerva Cardioangiol; 1999 Jun; 47(6):213-7. PubMed ID: 10522147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
    Chamot AM; Monti M
    Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon: clinical spectrum of 118 patients.
    De Angelis R; Del Medico P; Blasetti P; Cervini C
    Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic contribution and current concepts in nailfold capillary microscopy in rheumatology].
    Caleiro MT
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):104-10. PubMed ID: 9435405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO; Russell AS
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.